🇮🇹 Italy Country × Condition
coronary artery disease Clinical Trials in Italy
Active clinical trials for coronary artery disease with research sites in Italy. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 Phases: Phase 3 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇮🇹 Italy
Active Trials in Italy (5)
NCT06551662
Recruiting
DCB vs. DES in Bifurcation Coronary Lesions
Enrollment
321 pts
Country
🇮🇹 Italy
Fondazione Ricerca e Innovazione Ca...
View Trial → NCT07091682
Recruiting
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions
Enrollment
100 pts
Country
🇮🇹 Italy
Biotronik AG
View Trial → NCT01384721
Recruiting
Computed Tomography Coronary Angiography (CTCA) Prognostic Registry for Coronary Artery Disease
Enrollment
1,000 pts
Country
🇮🇹 Italy
Azienda Ospedaliero-Universitaria d...
View Trial → NCT04761068
Recruiting
Clinical Outcomes of Patients Undergoing CABG Surgery With VEST Supported Venous Grafts
Enrollment
1,000 pts
Country
🇮🇹 Italy
Cardiocentro Ticino
View Trial → NCT03789916 Phase 3
Recruiting
SAPT Versus DAPT in Incomplete Revascularization After CABG
Enrollment
800 pts
Country
🇮🇹 Italy
Campus Bio-Medico University
View Trial → Frequently Asked Questions
How many coronary artery disease clinical trials are active in Italy?
There are currently 5 active clinical trials for coronary artery disease with sites in Italy, of which 5 are actively recruiting patients.
How can I join a coronary artery disease clinical trial in Italy?
To join a coronary artery disease clinical trial in Italy, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Italy directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are coronary artery disease trials in Italy?
Active coronary artery disease trials in Italy span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.